Stock Analysis

Labixiaoxin Snacks Group Full Year 2024 Earnings: CN¥0.53 loss per share (vs CN¥0.79 loss in FY 2023)

SEHK:1262
Source: Shutterstock
Advertisement

Labixiaoxin Snacks Group (HKG:1262) Full Year 2024 Results

Key Financial Results

  • Revenue: CN¥866.7m (up 13% from FY 2023).
  • Net loss: CN¥93.5m (loss narrowed by 11% from FY 2023).
  • CN¥0.53 loss per share (improved from CN¥0.79 loss in FY 2023).
earnings-and-revenue-history
SEHK:1262 Earnings and Revenue History May 5th 2025

All figures shown in the chart above are for the trailing 12 month (TTM) period

Labixiaoxin Snacks Group shares are up 7.9% from a week ago.

Risk Analysis

You should always think about risks. Case in point, we've spotted 3 warning signs for Labixiaoxin Snacks Group you should be aware of, and 2 of them are a bit concerning.

New: AI Stock Screener & Alerts

Our new AI Stock Screener scans the market every day to uncover opportunities.

• Dividend Powerhouses (3%+ Yield)
• Undervalued Small Caps with Insider Buying
• High growth Tech and AI Companies

Or build your own from over 50 metrics.

Explore Now for Free

Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team (at) simplywallst.com.

This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.

About SEHK:1262

Labixiaoxin Snacks Group

An investment holding company, manufactures and sells jelly, confectionary, beverage, and other snack products in the People’s Republic of China.

Mediocre balance sheet low.

Advertisement